Literature DB >> 11506952

Expression of cyclooxygenase-2 (COX-2) mRNA in human colorectal adenomas.

K Hasegawa1, W Ichikawa, T Fujita, R Ohno, T Okusa, K Yoshinaga, K Sugihara.   

Abstract

Cyclooxygenase-2 (COX-2) is an important target for the suppression of colorectal tumorigenesis by non-steroidal anti-inflammatory drugs (NSAIDs). To evaluate the role of COX-2 in human sporadic colorectal adenomas, COX-2 mRNA expression was examined by reverse transcription-polymerase chain reaction (RT-PCR) in 63 adenomas. COX-2 mRNA was detected in all the adenomas at higher levels than in normal colorectal mucosa (P<0.001). Levels of expression in the adenomas were correlated with their size (P=0.019), but no relationships were demonstrable between COX-2 expression and adenoma location, macroscopically observed configuration or microscopic degree of dysplasia. These findings suggest that COX-2 plays an important role in the growth of sporadic colorectal adenomas.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11506952     DOI: 10.1016/s0959-8049(01)00137-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  12 in total

Review 1.  Cyclooxygenase-2 and thromboxane synthase in non-endocrine and endocrine tumors: a review.

Authors:  Onder Onguru; Mary B Casey; Sabine Kajita; Nobuki Nakamura; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Dose-dependent reduction of 3,2'-dimethyl-4-aminobiphenyl-derived DNA adducts in colon and liver of rats administered celecoxib.

Authors:  Srivani Ravoori; Yi Feng; Jason R Neale; Jeyaprakash Jeyabalan; Cidambi Srinivasan; David W Hein; Ramesh C Gupta
Journal:  Mutat Res       Date:  2007-09-14       Impact factor: 2.433

3.  The functional -765G→C polymorphism of the COX-2 gene may reduce the risk of developing crohn's disease.

Authors:  Hilbert S de Vries; Rene H M te Morsche; Martijn G H van Oijen; Iris D Nagtegaal; Wilbert H M Peters; Dirk J de Jong
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

4.  Induction of HSF1 expression is associated with sporadic colorectal cancer.

Authors:  Hui Cen; Shu Zheng; Yong-Ming Fang; Xiao-Ping Tang; Qi Dong
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

Review 5.  Cyclooxygenase-2 and its role in colorectal cancer development.

Authors:  Dominique Wendum; Joëlle Masliah; Germain Trugnan; Jean-François Fléjou
Journal:  Virchows Arch       Date:  2004-09-01       Impact factor: 4.064

6.  The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis.

Authors:  Lisa E Young; Sandhya Sanduja; Kristi Bemis-Standoli; Edsel A Pena; Robert L Price; Dan A Dixon
Journal:  Gastroenterology       Date:  2009-01-15       Impact factor: 22.682

7.  Expression of cyclooxygenase-2 (COX-2) in pituitary tumours.

Authors:  Grzegorz Sokołowski; Agata Bałdys-Waligórska; Małgorzata Trofimiuk; Dariusz Adamek; Alicja Hubalewska-Dydejczyk; Filip Gołkowski
Journal:  Med Sci Monit       Date:  2012-04

8.  Relation of the expression of cyclooxygenase-2 in colorectal adenomas and adenocarcinomas to angiogenesis and prognosis.

Authors:  Yoon Dae Han; Young Ki Hong; Jung Gu Kang; Yoon Jung Choi; Chan Heun Park
Journal:  J Korean Soc Coloproctol       Date:  2010-10-31

9.  Nitric Oxide (NO) and Cyclooxygenase-2 (COX-2) Cross-Talk in Co-Cultures of Tumor Spheroids with Normal Cells.

Authors:  Roman Paduch; Martyna Kandefer-Szerszeń
Journal:  Cancer Microenviron       Date:  2011-02-22

10.  JTE-522, a selective COX-2 inhibitor, inhibits growth of pulmonary metastases of colorectal cancer in rats.

Authors:  Hirotoshi Kobayashi; Hiroyuki Uetake; Tetsuro Higuchi; Masayuki Enomoto; Kenichi Sugihara
Journal:  BMC Cancer       Date:  2005-03-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.